NCT00249158View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

PHASE3CompletedINTERVENTIONAL

Enrollment

344

Participants

Timeline

Start Date

March 31, 1998

Study Completion Date

February 28, 2001

Conditions

DementiaAlzheimer DiseaseVascular Dementia

Interventions

DRUG

Risperidone

All Listed Sponsors

lead

Janssen-Cilag Pty Ltd

INDUSTRY